New injection aims to tackle sleep apnea and obesity in one shot

NCT ID NCT06974851

Summary

This study is testing an investigational injection called HRS9531 for adults with both obstructive sleep apnea and obesity who are not using a CPAP machine. Over 52 weeks, researchers will measure if the treatment improves nighttime breathing events, reduces daytime sleepiness, and helps with weight loss. The goal is to see if this single treatment can help control both conditions.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BSTRUCTIVE SLEEP APNEA (OSA) AND OBESITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Beijing Hospital

    RECRUITING

    Beijing, Beijing Municipality, 100034, China

    Contact

Conditions

Explore the condition pages connected to this study.